Related references
Note: Only part of the references are listed.Chemotherapy-induced neuropathy
Anthony J. Windebank et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2008)
Relationship between cytochrome 3A activity, inflammatory status and the risk of docetaxel-induced febrile neutropenia: a prospective study
J. Alexandre et al.
ANNALS OF ONCOLOGY (2007)
Association of ABCB1 genotypes with paclitaxel-mediated peripheral neuropathy and neutropenia
Tristan M. Sissung et al.
EUROPEAN JOURNAL OF CANCER (2006)
Accumulation of hydrogen peroxide is an early and crucial step for paclitaxel-induced cancer cell death both in vitro and in vivo
Jerome Alexandre et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Pharmacokinetics and toxicity of docetaxel:: Role of CYP3A, MDR1, and GST polymorphisms
A Tran et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Glutathione S-transferase P1 polymorphism (Ile105Val) predicts cumulative neuropathy in patients receiving oxaliplatin-based chemotherapy
Thierry Lecomte et al.
CLINICAL CANCER RESEARCH (2006)
Peripheral neuropathy induced by microtubule-stabilizing agents
JJ Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Glutathione S-transferase polymorphisms:: cancer incidence and therapy
CC McIlwain et al.
ONCOGENE (2006)
Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir
J Alexandre et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Amplification loop cascade for increasing caspase activity induced by docetaxel
DX Cao et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2005)
Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer
SE Jones et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats
E Persohn et al.
EUROPEAN JOURNAL OF CANCER (2005)
Prediction of docetaxel response in human breast cancer by gene expression profiling
K Iwao-Koizumi et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer
DP Petrylak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: The TAX 326 study group
F Fossella et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Increased constitutive c-Jun N-terminal kinase signaling in mice lacking glutathione S-transferase Pi
R Elsby et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Association between glutathione S-transferase p1 polymorphisms and lung cancer risk in Caucasians:: a case-control study
YF Wang et al.
LUNG CANCER (2003)
Allelic variants of the human glutathione S-transferase P1 gene confer differential cytoprotection against anticancer agents in Escherichia coli
TM Ishimoto et al.
PHARMACOGENETICS (2002)
Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: A randomized, double-blind, placebo-controlled trial
S Cascinu et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Increased resistance to acetaminophen hepatotoxicity in mice lacking glutathione S-transferase Pi
CJ Henderson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Glutathione S-transferase polymorphisms and their biological consequences
JD Hayes et al.
PHARMACOLOGY (2000)
Share Paper
